Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-008890

General Counsel sold 3,576 shares at $29.84 ($106,701)

  • General Counsel acquired 16,644 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-16 Sale : show line 1 in the form −3,576 $29.84 $106,701 6,136 D
2024-02-16 Grant or award : show line 2 in the form +16,644 22,780 D
Open-market sales · 3,576 sh · avg $29.84 · $106,701

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-16 Grant or award : show line 3 in the form Stock Option (Right to Buy) +49,091 49,091 D
Loading xslF345X05/form4.xml…